TSTL Tristel plc

5.096USD387.50 GBp · LSE+0.65%Mkt Cap: 244.99M USDP/E: 22.79

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. It operates through three segments: Hospital Medical Device Deco…

Institutional holders3 on file

Key Statistics

Company
Market Cap244.99M USD
Enterprise Value231.26M USD
Revenue (TTM)67.23M USD
Gross Profit55.94M USD
Net Income (TTM)10.50M USD
Revenue/Share1.40 USD
Last Price5.096 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees282
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINGB00B07RVT99
Valuation
P/E (Trailing)22.79
P/E (Forward)17.82
PEG—
EV/EBITDA13.35
EV/Revenue3.44
P/S3.64
P/B5.21
EPS (TTM)0.22 USD
EPS (Forward)0.29 USD
52W Range
4.60338% of range5.918
52W High5.918 USD
52W Low4.603 USD
Profitability
Gross Margin83.21%
Oper. Margin21.87%
EBITDA Margin25.77%
Profit Margin15.62%
ROE23.24%
ROA14.93%
ROIC—
ROCE—
Growth
Revenue Growth6.60%
Earnings Growth3.10%
Cash Flow & Leverage
Operating CF13.57M USD
CapEx (TTM)2.61M USD
FCF Margin16.71%
FCF Yield4.59%
Net Debt-13.34M USD
Net Debt/EBITDA-0.77
Net Debt/FCF-1.19
Balance Sheet
Debt/Equity0.18
Current Ratio4.00
Quick Ratio3.43
Book Value/Sh0.98 USD
Cash/Share0.44 USD
Dividends
Fwd Div Rate0.0018 USD
Trail. Div Rate0.0020 USD
Div. Yield3.69%
5Y Avg Yield2.47%
Payout Ratio85.70%
Ex-Div DateNov 26, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.190 USD
Upside (mean)+21.5%
Target Range5.261 USD – 7.365 USD
5.261+21.5% to mean7.365
# Analysts6
Ownership
Shares Out.48.07M
Float46.32M
Insiders2.36%
Institutions48.21%
Technical
SMA 505.332 (-4.4%)
SMA 2005.236 (-2.7%)
Beta0.33
S&P 52W Chg8.68%
Avg Vol (30d)84.90K
Avg Vol (10d)111.21K
Technical Indicators
RSI (14)36.7
MACD-5.8135
MACD Signal-5.2980
MACD Hist.-0.5156
BB Upper5.407 USD
BB Middle5.209 USD
BB Lower5.011 USD
BB Width7.60%
ATR (14)0.1815 USD
Vol Ratio (20d)1.54x

About Tristel (LON: TSTL)

›

Tristel (LON: TSTL) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 282 employees.

The shares were at 387.50 GBp on 20 November 2026, up 4.8% over 52 weeks. Its 52-week range is 350.00 GBp to 450.00 GBp: the price is 13.9% below the high and 10.7% above the low.

At a market capitalisation of 186.28M GBP, it trades at 22.8 times trailing earnings and 17.8 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, a discount of 53% for TSTL. It pays a dividend yielding 3.69% (it pays out 86% of its earnings), against a median of 0.92% among the dividend payers in that peer group.

Tristel reports return on equity of 23.2%, an operating margin of 21.9% and revenue up 6.6% year over year.

It holds more cash than debt, a net cash position of 10.15M GBP. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 6 analysts cover the stock; their mean price target of 470.67 GBp is 21.5% above the current price.